Şunu aradınız:: addoloxxenti (Maltaca - İngilizce)

tfal u addoloxxenti
children and adolescents

adulti u addoloxxenti
adults and adolescents

l-użu fi tfal u addoloxxenti
use in children and adolescents

dożaġġ rikkmandat għal tfal u addoloxxenti
dosage recommendations for children and adolescents:

dożaġġ rikkmandat għat- tfal u addoloxxenti:
dose recommendations for children and adolescents:

is-sigurtà tat-tfal u l-addoloxxenti;
safety of children and adolescents;

adulti u addoloxxenti ‘ l fuq minn 12- il sena:
adults and adolescents over 12 years of age:

doża fl-adulti u addoloxxenti (minn 16-il sena)
dose in adults and adolescents (from 16 years of age)

monoterapija għal adulti u addoloxxenti minn 16-il sena ‘l fuq.
monotherapy for adults and adolescents from 16 years of age

- osseor mhux indikat għall- użu fit- tfal u fl- addoloxxenti.
- osseor is not intended for use in children and adolescents.

vimpat mhux rikkmandat għal tfal u addoloxxenti ta’ taħt is-16-il sena.
vimpat is not recommended for children and adolescents aged under 16 years.

cimzia mhux irrakkomandat għal tfal u addoloxxenti ta’ taħt it-tmintax-il sena.
cimzia is not recommended for use in children and adolescents under the age of 18 years.

arixtra ma ġietx ittestjata fi tfal u addoloxxenti ta’ taħt is-17-il sena.
arixtra has not been tested in children and adolescents under the age of 17 years.

tfal arixtra ma ġietx ittestjata fi tfal u addoloxxenti ta ’ taħt is- 17- il sena.
children arixtra has not been tested in children and adolescents under the age of 17 years.

t za tfal quixidar ma ġiex ittestjat fi tfal u addoloxxenti ta ’ taħt is- 17- il sena.
children quixidar has not been tested in children and adolescents under the age of 17 years.

din l-għamla għandha tinkiteb għal tfal t’ 4 snin ‘l fuq, addoloxxenti u adulti.
this presentation should be prescribed for children aged 4 years and older, adolescents and adults.

dożaġġ f’adulti u addoloxxenti (12 sa 17 il-sena) li jiżnu 50 kg jew iżjed
dose in adults and adolescents (12 to 17 years) weighing 50 kg or more:

tfal arixtra ma ’ ġietx ippruvata f’ tfal u addoloxxenti ta ’ taħt is- 17- il sena.
children arixtra has not been tested in children and adolescents under the age of 17 years.

regolar tad-doża f'pazjenti adulti u addoloxxenti li jiżnu iżjed minn 50kg b’ indeboliment fil-kliewi
dosing adjustment for adult and adolescents patients weighing more than 50 kg with impaired renal function

is-sigurta` u l-effikaċja ta’ rotigotine fit-tfal u addoloxxenti ghad ma ġietx stabbilita.
the safety and efficacy of rotigotine in children and adolescents have not yet been established.